Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn about a recent article by Yoann Huguenin et al, published in Seminars in Thrombosis and Hemostasis:
”100 years of von Willebrand disease (VWD).
When is a ‘subtype’ of VWD not really VWD?
Platelet type VWD is a disorder of the platelet VWF receptor GPIb, so is not really a defect of VWF.”
Title: Second Report of A GPIbα LRR7 Variant (P.Leu194Phe) Supporting the Pathogenicity of Mutations Outside The C-Terminal Domain In Platelet-Type Von Willebrand Disease
Authors: Yoann Huguenin, Anne Ryman, Mathieu Fiore
Read the Full Article on Seminars in Thrombosis and Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026